Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank
Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.
Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).
Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.
Talk to the deal team
Marie Gabriella Sestini
BlijWerkt has been acquired by Mentha Capital
Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.Learn more
Lead Healthcare has successfully raised financing provided by Rabobank
Lead Healthcare has successfully raised financing provided by Rabobank.Learn more
ERBC (ex CERB) has acquired RTC
The European Research Biology Center (ERBC) has acquired the Research Toxicology Center (RTC).Learn more